MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration.
$14.25+6.90%
报价 2026-11-06
市值
$184M
EV
$187.3M
PE (TTM)
–
预期 PE
–
52 周区间距高点 -26.4%
$11.85$19.37
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
excluded industry: Biotechnology
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
同行业市值相近 · Biotechnology| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| MDWDMediWound Ltd. | $184M | +6.9% | – | 19.2% | – | – | – | |
| IFRXInflaRx N.V. | $192.3M | -3.7% | – | 48,201.6% | – | – | – | |
| PRQRProQR Therapeutics N.V. | $190.5M | +1.5% | – | 92.3% | – | – | – | |
| TRDAEntrada Therapeutics, Inc. | $190.4M | +7.5% | -36.1% | -754.7% | – | – | – | |
| CGENCompugen Ltd. | $185.7M | +2.1% | – | 86.9% | 7.6x | 7.5x | – | |
| KROSKeros Therapeutics, Inc. | $185.6M | -1.0% | -98.5% | 96.5% | – | – | – | |
| WHWKWhitehawk Therapeutics Inc | $178.4M | +3.6% | +23.9% | 0% | – | – | – | |
| CTYCity Therapeutics Inc. | $177.4M | +6.9% | – | – | – | – | – | |
| UPBUpstream Bio, Inc. | $176.9M | +0.6% | -22.2% | 98.5% | – | – | – | |
| 同行中位数 | – | – | -29.1% | 92.3% | 7.6x | 7.5x | – |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。